Reckitt sales blow hot

BUMPER US sales of a new footcare brand and demand for its flu remedies helped Nurofen maker Reckitt Benckiser step up profit growth.

BLOOMBERG

Reckitt Benckiser make Nurofen

A focus on higher margin health and hygiene products as customers seek more over-the-counter treatments is paying off for the FTSE 100 group behind Dettol, Durex and Air Wick, as it posted 5 per cent higher like-for-like half-year revenue to £4.35billion, with operating profit up 10 per cent to £939million.

Advertisement

Chief executive Rakesh Kapoor highlighted the successful launch of its Amope pedicure product in America and a “favourable” flu season. It expects to exceed revenue and profit targets for the year. Shares rose 85p to 5993p.

Get personal finance news, money saving tips and advice plus selcted offers and competitions
Invalid email Invalid email

You agree you are 18 or over. We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and third parties based on our knowledge of you. You can unsubscribe at any time. More Info.

PREMIUM ARTICLES

NEWS

POLITICS

ROYAL

SHOWBIZ & TV

SPORT

FINANCE

TRAVEL

LIFE & STYLE

F1

TENNIS